Table 6 COVID-19 PCR positivity among the patients throughout the study
From: Clinical disease activity in autoimmune rheumatic patients receiving COVID-19 vaccines
Follow-up period | |||||||
|---|---|---|---|---|---|---|---|
Baseline | Week 1 | Week 3 | Week 6 | Week 12 | Month 6 | Month 12 | |
N = 38 | N = 38 | N = 38 | N = 38 | N = 37 | N = 37 | N = 35 | |
n/N (%) | n/N (%) | n/N (%) | n/N (%) | n/N (%) | n/N (%) | n/N (%) | |
COVID-19 PCR test results | |||||||
Negative | 28/38 (73.7%) | 36/38 (94.7%) | 37/38 (97.4%) | 38/38 (100.0%) | 37/37 (100.0%) | 37/37 (100.0%) | 35/35 (100.0%) |
Positive | 10/38 (26.3%) | 2/38 (5.3%) | 1/38 (2.6%) | 0/38 (0.0%) | 0/38 (0.0%) | 0/38 (0.0%) | 0/38 (0.0%) |